Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) YoY EBITDA Growth : -66.01% (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Beijing Sun-Novo Pharmaceutical Research Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Beijing Sun-Novo Pharmaceutical Research Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -66.01%.

Beijing Sun-Novo Pharmaceutical Research Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.24.

Beijing Sun-Novo Pharmaceutical Research Co YoY EBITDA Growth Historical Data

The historical data trend for Beijing Sun-Novo Pharmaceutical Research Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Sun-Novo Pharmaceutical Research Co YoY EBITDA Growth Chart

Beijing Sun-Novo Pharmaceutical Research Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

49.07

40.70

24.48

14.25

-3.62

Beijing Sun-Novo Pharmaceutical Research Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															45.01	7.46	17.88	-382.03	-66.01

Beijing Sun-Novo Pharmaceutical Research Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Beijing Sun-Novo Pharmaceutical Research Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(2.156	-	2.237)	/	\| 2.237 \|
=	-3.62 %

Beijing Sun-Novo Pharmaceutical Research Co's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(0.242	-	0.712)	/	\| 0.712 \|
=	-66.01 %

Beijing Sun-Novo Pharmaceutical Research Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Beijing Sun-Novo Pharmaceutical Research Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Sun-Novo Pharmaceutical Research Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Sun-Novo Pharmaceutical Research Co Ltd (SHSE:688621) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

No. 79 Shuangying West Road, 1st Floor, Building 7, Science Park, Changping District, Beijing, CHN, 102200

Website

http://www.sun-novo.com

Beijing Sun-Novo Pharmaceutical Research Co Ltd is engaged in providing professional research and development outsourcing services for pharmaceutical companies.

Executives

Liu Yu Jing	Directors, senior managers
Shao Yan	Director
Zhao Ling Yang	Director
Li Qian	Director

Beijing Sun-Novo Pharmaceutical Research Co Headlines

No Headlines